Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a β-arrestin 2 dependent manner

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 73-79

  Li, Hui ^a,b   Chen, Lin ^a   Zhang, Ying ^c   LeSage, Gene ^a   Zhang, Yi ^a   Wu, Yan ^b   Hanley, Gregory ^a   Sun, Shenggang ^b   Yin, Deling ^a  

^a East Tennessee State University   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Arrestin 2; Akt; Lymphocytes; PI3K; Stress; TLR2

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA ARRESTIN 2; LIPOPEPTIDE; PEPTIDOGLYCAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; WORTMANNIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMOBILIZATION STRESS; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; ARRESTINS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TOLL-LIKE RECEPTOR 2;

EID: 79953305642     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.11.015     Document Type: Article

References (55)

1. Abrahams V.M., Aldo P.B., Murphy S.P., Visintin I., Koga K., Wilson G., Romero R., Sharma S., Mor G. TLR6 modulates first trimester trophoblast responses to peptidoglycan. J. Immunol. 2008, 180:6035-6043.
2. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
3. Adi S., Wu N.Y., Rosenthal S.M. Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin. Endocrinology 2001, 142:498-501.
4. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., Godowski P.J., Ulevitch R.J., Knaus U.G. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 2000, 1:533-540.
5. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005, 122:261-273.
6. Beaulieu J.M., Marion S., Rodriguiz R.M., Medvedev I.O., Sotnikova T.D., Ghisi V., Wetsel W.C., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 2008, 132:125-136.
7. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
8. Cao L., Hudson C.A., Moynihan J.A. Chronic foot shock induces hyperactive behaviors and accompanying pro- and anti-inflammatory responses in mice. J. Neuroimmunol. 2007, 186:63-74.
9. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003, 197:403-411.
10. Dhabhar F.S., McEwen B.S. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 1997, 11:286-306.
11. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:1059-1064.
12. Doyle S.L., O'Neill L.A. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 2006, 72:1102-1113.
13. Fong A.M., Premont R.T., Richardson R.M., Yu Y.R., Lefkowitz R.J., Patel D.D. Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:7478-7483.
14. Frieri M. Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann. Allergy Asthma Immunol. 2003, 90:34-40.
15. Fruman D.A., Cantley L.C. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 2002, 14:7-18.
16. Fukao T., Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 2003, 24:358-363.
17. Fukao T., Tanabe M., Terauchi Y., Ota T., Matsuda S., Asano T., Kadowaki T., Takeuchi T., Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 2002, 3:875-881.
18. Gan L., Li L. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity. Immunol. Res. 2006, 35:295-302.
19. Guha M., Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 2002, 277:32124-32132.
20. Ha T., Lu C., Liu L., Hua F., Hu Y., Kelley J., Singh K., Kao R.L., Kalbfleisch J., Williams D.L., Gao X., Li C. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H984-H991.
21. Hawkley L.C., Cacioppo J.T. Stress and the aging immune system. Brain Behav. Immun. 2004, 18:114-119.
22. Kaisho T., Akira S. Regulation of dendritic cell function through Toll-like receptors. Curr. Mol. Med. 2003, 3:373-385.
23. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002, 3:221-227.
24. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
25. Li C., Ha T., Kelley J., Gao X., Qiu Y., Kao R.L., Browder W., Williams D.L. Modulating Toll-like receptor mediated signaling by (1→3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc. Res. 2004, 61:538-547.
26. Li Y., Sun X., Zhang Y., Huang J., Hanley G., Ferslew K.E., Peng Y., Yin D. Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2. Biochem. Biophys. Res. Commun. 2009, 378:857-861.
27. Li H., Sun X., LeSage G., Zhang Y., Liang Z., Chen J., Hanley G., He L., Sun S., Yin D. Beta-Arrestin 2 regulates toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3beta. Immunology 2010, 130:556-563.
28. Luan B., Zhang Z., Wu Y., Kang J., Pei G. Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation. EMBO J. 2005, 24:4237-4246.
29. Marmiroli S., Bavelloni A., Faenza I., Sirri A., Ognibene A., Cenni V., Tsukada J., Koyama Y., Ruzzene M., Ferri A., Auron P.E., Toker A., Maraldi N.M. Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 1998, 438:49-54.
30. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., Goldfarb R.H., Kitson R.P., Miller A.H., Spencer R.L., Weiss J.M. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Brain Res. Rev. 1997, 23:79-133.
31. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
32. Moore C.A., Milano S.K., Benovic J.L. Regulation of receptor trafficking by GRKs and arrestins. Annu. Rev. Physiol. 2007, 69:451-482.
33. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 2003, 33:597-605.
34. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
35. Quan N., Avitsur R., Stark J.L., He L., Shah M., Caligiuri M., Padgett D.A., Marucha P.T., Sheridan J.F. Social stress increases the susceptibility to endotoxic shock. J. Neuroimmunol. 2001, 115:36-45.
36. Reiche E.M., Nunes S.O., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004, 5:617-625.
37. Revankar C.M., Vines C.M., Cimino D.F., Prossnitz E.R. Arrestins block G protein-coupled receptor-mediated apoptosis. J. Biol. Chem. 2004, 279:24578-24584.
38. Ruse M., Knaus U.G. New players in TLR-mediated innate immunity: PI3K and small Rho GTPases. Immunol. Res. 2006, 34:33-48.
39. Santos-Sierra S., Deshmukh S.D., Kalnitski J., Kuenzi P., Wymann M.P., Golenbock D.T., Henneke P. Mal connects TLR2 to PI3 kinase activation and phagocyte polarization. EMBO J. 2009, 28:2018-2027.
40. Sarkar S.N., Peters K.L., Elco C.P., Sakamoto S., Pal S., Sen G.C. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 2004, 11:1060-1067.
41. Shi Y., Devadas S., Greeneltch K.M., Yin D., Allan M.R., Zhou J.N. Stressed to death: implication of lymphocyte apoptosis for psychoneuroimmunology. Brain Behav. Immun. 2003, 17(Suppl 1):S18-S26.
42. Wang Y., Tang Y., Teng L., Wu Y., Zhao X., Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 2006, 7:139-147.
43. Witherow D.S., Garrison T.R., Miller W.E., Lefkowitz R.J. beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8603-8607.
44. Xu D., Komai-Koma M., Liew F.Y. Expression and function of Toll-like receptor on T cells. Cell. Immunol. 2005, 233:85-89.
45. Yang E.V., Glaser R. Stress-associated immunomodulation and its implications for responses to vaccination. Expert Rev. Vaccines 2002, 1:453-459.
46. Yin D., Zhang L., Wang R., Radvanyi L., Haudenschild C., Fang Q., Kehry M.R., Shi Y. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. J. Immunol. 1999, 163:4328-4334.
47. Yin D., Tuthill D., Mufson R.A., Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J. Exp. Med. 2000, 191:1423-1428.
48. Yin D., Woodruff M., Zhang Y., Whaley S., Miao J., Ferslew K., Zhao J., Stuart C. Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways. J. Neuroimmunol. 2006, 174:101-107.
49. Yin D., Zhang Y., Stuart C., Miao J., Zhang Y., Li C., Zeng X., Hanley G., Moorman J., Yao Z., Woodruff M. Chronic restraint stress modulates expression of genes in murine spleen. J. Neuroimmunol. 2006, 177:11-17.
50. Zanin-Zhorov A., Tal-Lapidot G., Cahalon L., Cohen-Sfady M., Pevsner-Fischer M., Lider O., Cohen I.R. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J. Immunol. 2007, 179:41-44.
51. Zhang G., Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J. Clin. Invest. 2001, 107:13-19.
52. Zhang Y., Foster R., Sun X., Yin Q., Li Y., Hanley G., Stuart C., Gan Y., Li C., Zhang Z., Yin D. Restraint stress induces lymphocyte reduction through p53 and PI3K/NF-kappaB pathways. J. Neuroimmunol. 2008, 200:71-76.
53. Zhang Y., Woodruff M., Zhang Y., Miao J., Hanley G., Stuart C., Zeng X., Prabhakar S., Moorman J., Zhao B., Yin D. Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression. J. Neuroimmunol. 2008, 194:115-122.
54. Zhang Y., Zhang Y., Miao J., Hanley G., Stuart C., Sun X., Chen T., Yin D. Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. J. Neuroimmunol. 2008, 204:13-19.
55. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 2001, 15:199-226.